We observed a significantly lower left ventricular ejection fraction in carriers of high-impact loss-of-function PTPRG variants compared to non-carriers (Figure 7D) consistent with the greater risk of ischemic heart disease (Figure 7C). This evidence concerns the gene PTPRG and coronary artery disorder.